Public procurement notice: Contract Notice
Published: 2018-04-25
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products
Estimated value: 3278908 GBP
Submission deadline: 2018-05-28
Award criteria: The most economic tender

Technical requirements: Supply of Trastuzumab powder for reconstitution for intravenous infusion to health boards across NHS Scotland. The procurement will include 150 mg and 440 mg vials.
All entities constituted pursuant to the national health services (Scotland) Act 1978, and any integrated joint boards established pursuant to new public bodies (joint working) Scotland Act 2014.
Supply of Trastuzumab powder for reconstitution for intravenous infusion to health boards across NHS Scotland. The authority intends awarding an unranked multi-supplier framework agreement. Each product line will be treated as an individual lot and will be awarded to an envisaged maximum of 4 potential framework participants.
Option to extend by a further 2 periods of 12 months upon giving not less than 3 months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Access to contract pricing is required by the designated compounding company for supply to participating authorities across NHS Scotland.
Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the public contracts (Scotland) Regulations 2015.
a— Potential framework participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered medicines at the date of submission of the tender,
b— potential framework participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
a— Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered medicines at the date of submission of the tender should be included in the qualification envelope of the ITT under the technical and professional ability: quality control.
b— Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under technical and professional ability: quality assurance schemes.
The estimated values referred to in Section II.I.5 and II.2.6 covers the 18 months contract duration and the two 12 months extension periods of the framework agreement.
The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 10760. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343
The authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operator was unsuccessful. The notification will incorporate a “standstill period” of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the authority despatches the notice(s) and the date on which the authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the public contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the public contracts (Scotland) Regulations 2015.

Award value: 3278908